The International Herpes Management Forum (IHMF) has published guidelines for the
diagnosis and management of cytomegalovirus (CMV) infection and disease in solid organ …

Cytomegalovirus (CMV) results in significant morbidity and mortality following hematopoietic
cell transplantation (HCT). Establishing the cost and clinical impact is imperative to the …

The landscape of CMV prevention is about to change with the approval of a new anti-CMV
antiviral that is safe and effective. However, the prophylaxis may lead to late onset CMVi in …

This review focuses on recent advances in the field of cytomegalovirus (CMV). The 2 main
strategies for CMV prevention are prophylaxis and preemptive therapy. Prophylaxis …

Abstract The 2023 International CMV Symposium took place in Barcelona in May 2023.
During the 2‐day meeting, delegates and faculty discussed the ongoing challenge of …

Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality after
hematopoietic stem cell transplantation (HSCT). Limited data are available from developing …

The role of cytomegalovirus serostatus on outcome of hematop... : Current Opinion in
Hematology The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell …

Background We aimed to investigate factors associated with cytomegalovirus (CMV) viremia
and CMV disease and its impact on post-transplant outcomes including overall survival (OS) …

Background Viral infections are a major cause of morbidity and mortality after hematopoietic
stem cell transplantation (HSCT). The effect of herpesvirus infections in human …

Introduction Cytomegalovirus (CMV) is an opportunistic infection that affects
immunocompromised solid organ transplant patients. Defining the imbalance between host …